HUE036797T2 - Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai - Google Patents

Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai

Info

Publication number
HUE036797T2
HUE036797T2 HUE13767175A HUE13767175A HUE036797T2 HU E036797 T2 HUE036797 T2 HU E036797T2 HU E13767175 A HUE13767175 A HU E13767175A HU E13767175 A HUE13767175 A HU E13767175A HU E036797 T2 HUE036797 T2 HU E036797T2
Authority
HU
Hungary
Prior art keywords
methods
application
oleanolic acid
heteroaryl derivatives
heteroaryl
Prior art date
Application number
HUE13767175A
Other languages
English (en)
Hungarian (hu)
Inventor
Xin Jiang
Christopher Bender
Melean Visnick
Original Assignee
Reata Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc
Publication of HUE036797T2 publication Critical patent/HUE036797T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Epidemiology (AREA)
HUE13767175A 2012-09-10 2013-09-10 Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai HUE036797T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261699199P 2012-09-10 2012-09-10

Publications (1)

Publication Number Publication Date
HUE036797T2 true HUE036797T2 (hu) 2018-07-30

Family

ID=49253401

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13767175A HUE036797T2 (hu) 2012-09-10 2013-09-10 Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai

Country Status (28)

Country Link
US (1) US20140088163A1 (enExample)
EP (1) EP2892911B1 (enExample)
JP (1) JP6272870B2 (enExample)
KR (1) KR102237364B1 (enExample)
CN (1) CN104768965B (enExample)
AU (1) AU2013312102B2 (enExample)
BR (1) BR112015005200B1 (enExample)
CA (1) CA2882417C (enExample)
CY (1) CY1119762T1 (enExample)
DK (1) DK2892911T3 (enExample)
EA (1) EA029069B1 (enExample)
ES (1) ES2644615T3 (enExample)
HR (1) HRP20171565T1 (enExample)
HU (1) HUE036797T2 (enExample)
IL (1) IL237638B (enExample)
IN (1) IN2015DN01547A (enExample)
LT (1) LT2892911T (enExample)
ME (1) ME02911B (enExample)
MX (1) MX366954B (enExample)
NZ (1) NZ705213A (enExample)
PL (1) PL2892911T3 (enExample)
PT (1) PT2892911T (enExample)
RS (1) RS56563B1 (enExample)
SG (1) SG11201501800UA (enExample)
SI (1) SI2892911T1 (enExample)
SM (1) SMT201700501T1 (enExample)
WO (1) WO2014040056A1 (enExample)
ZA (1) ZA201501203B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739841B (zh) 2008-01-11 2018-06-01 里亚塔医药公司 合成三萜类化合物及用以治病之方法
US8124799B2 (en) 2008-04-18 2012-02-28 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
BRPI0911105B1 (pt) 2008-04-18 2022-11-08 Reata Pharmaceuticals, Inc Compostos contendo um farmacóforo anti-inflamatório, composição farmacêutica, bem como seus usos
ME02973B (me) 2010-12-17 2018-07-20 Reata Pharmaceuticals Inc Pirazolil i pirimidinil triciklični enoni kao antioksidantni modulatori inflamacije
PT3444261T (pt) 2012-04-27 2021-03-12 Reata Pharmaceuticals Inc Derivados de 2,2-difluoropropionamida de metil bardoxolona, formas polimorfas e métodos de uso dos mesmos
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
TWI630212B (zh) 2012-09-10 2018-07-21 瑞塔醫藥有限責任公司 丁香油素(oleanolic acid)之c17-烷二基與烯二基衍生物及其使用方法
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
UY39092A (es) 2013-04-24 2021-03-26 Abbvie Inc Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
WO2016130927A1 (en) 2015-02-12 2016-08-18 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant iflammation modulators
AU2016326704B2 (en) 2015-09-23 2021-01-28 Reata Pharmaceuticals, Inc. C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
BR112019009256A2 (pt) 2016-11-08 2019-07-16 Reata Pharmaceuticals Inc métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo
CN106632574B (zh) * 2016-12-07 2018-05-29 广东天键生物科技有限公司 一种化合物、其制备方法及用途
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
RU2758376C2 (ru) 2017-09-14 2021-10-28 Феникс Байотекнолоджи, Инк. Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний
JP6820450B2 (ja) 2017-09-14 2021-01-27 フェニックス・バイオテクノロジー・インコーポレイテッド ウイルス感染を治療するための方法および組成物
CA3103726A1 (en) 2018-06-15 2019-12-19 Reata Pharmaceuticals, Inc. Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma
WO2019246461A1 (en) 2018-06-20 2019-12-26 Reata Pharmaceuticals, Inc. Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
CA3114354A1 (en) * 2018-09-28 2020-04-02 Sichuan Haisco Pharmaceutical Co., Ltd. Terpinoid derivatives and uses thereof
AU2020316351A1 (en) * 2019-07-19 2022-02-17 Reata Pharmaceuticals, Inc. C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
WO2021201903A1 (en) 2020-03-31 2021-10-07 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
JP7214696B2 (ja) * 2020-10-01 2023-01-30 一般財団法人 化学物質評価研究機構 新規in vitro皮膚感作性試験法
WO2022126129A1 (en) 2020-12-11 2022-06-16 Reata Pharmaceuticals, Inc. Synthetic triterpenoids for use in therapy
CN117015548A (zh) 2021-01-18 2023-11-07 里亚塔医药公司 合成的熊果酸衍生物和其使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
CA2485565A1 (en) * 2002-05-13 2004-08-05 Trustees Of Dartmouth College Inhibitors and methods of use thereof
CN104739841B (zh) 2008-01-11 2018-06-01 里亚塔医药公司 合成三萜类化合物及用以治病之方法
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721666C (en) * 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
US8124799B2 (en) * 2008-04-18 2012-02-28 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
TWI442925B (zh) * 2008-04-18 2014-07-01 Reata Pharmaceuticals Inc 抗氧化性發炎調節劑:c-環飽和之齊墩果酸衍生物
UY33946A (es) * 2011-03-11 2012-08-31 Reata Pharmaceuticals Inc Derivados de c4-monometil triterpenoides y sus métodos de uso
US9556222B2 (en) * 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

Also Published As

Publication number Publication date
WO2014040056A1 (en) 2014-03-13
MX366954B (es) 2019-07-31
BR112015005200B1 (pt) 2022-07-05
ZA201501203B (en) 2021-08-25
SI2892911T1 (sl) 2017-12-29
LT2892911T (lt) 2017-11-10
IL237638B (en) 2020-04-30
KR20150053982A (ko) 2015-05-19
HK1211295A1 (en) 2016-05-20
AU2013312102B2 (en) 2018-03-08
AU2013312102A1 (en) 2015-03-12
IN2015DN01547A (enExample) 2015-07-03
JP2015529227A (ja) 2015-10-05
BR112015005200A2 (enExample) 2017-08-15
ES2644615T3 (es) 2017-11-29
RS56563B1 (sr) 2018-02-28
US20140088163A1 (en) 2014-03-27
KR102237364B1 (ko) 2021-04-06
IL237638A0 (en) 2015-04-30
CA2882417C (en) 2021-04-20
ME02911B (me) 2018-10-20
EA201590539A1 (ru) 2015-08-31
DK2892911T3 (en) 2017-10-23
CN104768965B (zh) 2018-05-11
EA029069B1 (ru) 2018-02-28
PL2892911T3 (pl) 2018-03-30
NZ705213A (en) 2018-07-27
SG11201501800UA (en) 2015-04-29
JP6272870B2 (ja) 2018-01-31
MX2015003078A (es) 2015-07-14
PT2892911T (pt) 2017-11-02
CN104768965A (zh) 2015-07-08
SMT201700501T1 (it) 2017-11-15
CY1119762T1 (el) 2018-06-27
CA2882417A1 (en) 2014-03-13
HRP20171565T1 (hr) 2017-12-15
EP2892911A1 (en) 2015-07-15
EP2892911B1 (en) 2017-08-30

Similar Documents

Publication Publication Date Title
HUE036797T2 (hu) Oleanolsav C17-heteroaril-származékai és azok alkalmazási eljárásai
DK2892912T3 (da) C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf
HUE042516T2 (hu) Javított eljárás treprosztinilnek és származékainak elõállítására
HUE040111T2 (hu) Vegyületek és alkalmazási eljárásaik
HUE039915T2 (hu) Anthelmintikus vegyületek és készítmények és alkalmazásuk eljárása
DK2683731T3 (da) C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf
PL2969227T3 (pl) Formulacja octanu abirateronu
HUE042271T2 (hu) Emberi EZH2 inhibitorai és azok alkalmazási eljárásai
HUE046292T2 (hu) Melanóma kezelése és diagnosztizálása
IL242394B (en) Cenicriviroc compositions and methods of making and using the same
IL229963A0 (en) Substituted quinolines and their use as medicaments
IL238662A0 (en) Bendamustine derivatives and methods of using them
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
IL235968B (en) Polysaccharide compositions and methods of use
FI20125888A7 (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
IL235909A0 (en) Heteroaryl compounds and methods of use thereof
IL233875A (en) Composition and use thereof in the treatment of anal rhagades
EP2986112A4 (en) PREPARATION AND USE OF FULVINIC ACID DERIVATIVES
EP2811295A4 (en) SEPARATION AGENT AND METHOD FOR MANUFACTURING SAME
IL240447A0 (en) Propionic-biaryl acid derivatives and their use as pharmaceutical preparations
PL398988A1 (pl) (Z)-6-O-ß-D-glukopiranozylo-4'-hydroksy-4-metoksy-7-prenyloauron i sposób jego wytwarzania
IL240422B (en) Bi-aryl derivatives of propionic acid and their use as medicinal preparations
TH1401003816A (th) องค์ประกอบ, การสังเคราะห์, และ วิธีการของการใช้อนุพันธ์ฟีนิลไซโคลอัลคิลเมทธิลเอมีน
TH148762B (th) อนุพันธ์ของพิร์โรลิดีน-3-อิลแอซีติก แอซิด